LGC
AGN

Laurel Grove Capital’s Allergan plc AGN Stock Holding History

Laurel Grove Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,028
Closed -$2.26M – 103
2017
Q3 		$2.26M Sell
11,028
-1,150
-9% -$267K 1.18% 27
2017
Q2 		$2.96M Buy
12,178
+713
+6% +$168K 1.57% 24
2017
Q1 		$2.74M Sell
11,465
-548
-5% -$128K 1.44% 26
2016
Q4 		$2.52M Buy
12,013
+1,555
+15% +$322K 1.37% 27
2016
Q3 		$2.41M Buy
10,458
+880
+9% +$215K 1.38% 27
2016
Q2 		$2.21M Sell
9,578
-1,796
-16% -$414K 1.33% 27
2016
Q1 		$3.05M Sell
11,374
-2,340
-17% -$670K 1.73% 21
2015
Q4 		$4.29M Buy
13,714
+720
+6% +$214K 2.41% 9
2015
Q3 		$3.53M Buy
12,994
+3,022
+30% +$928K 2.02% 13
2015
Q2 		$3.03M Buy
9,972
+1,518
+18% +$453K 1.61% 20
2015
Q1 		$2.52M Buy
+8,454
New +$2.41M 1.35% 27

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Laurel Grove Capital's AGN Position: Q4 2017 in Review

Laurel Grove Capital sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 11,028 shares — an estimated $2.26M sold.

Laurel Grove Capital first reported a position in AGN in Q1 2015 and held it in 11 quarters. The position peaked at $4.29M in Q4 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Laurel Grove Capital reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Laurel Grove Capital sold 11,028 Allergan plc shares in Q4 2017, an estimated $2.26M.
  • Laurel Grove Capital first reported a position in Allergan plc in Q1 2015 and held it in 11 quarters.
  • Laurel Grove Capital's Allergan plc position peaked at $4.29M in Q4 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Laurel Grove Capital's 13F filing for Q4 2017, filed 23 Jan 2018.